Skip to content

Study of a homoeopathic medicine (Gambogia) for relieving symptoms in people with Irritable Bowel Syndrome (IBS)

A Clinical study to Evaluate the efficacy of homoeopathic medicine Gambogia in the cases of Irritable Bowel Syndrome (IBS) - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/106557
Enrollment
36
Registered
2026-03-19
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K582- Mixed irritable bowel syndrome

Interventions

Intervention1: Gambogia: Selected medicine will be given on the basis of Homoeopathic posology and follow up should be done in 2 weeks interval for about 1 to 3 month Control Intervention1: NIL: Not

Sponsors

RBTS Govt Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Adult aged 18-65 years of both sex. 2. diagnosis of IBS by Rome iv Criteria. 3. IBS symptom severity score (IBS-SSS)more than equal to 175 (moderate to severe)- optimal threshold. 4. Stable medications (no changes in IBS meds in prior 4 weeeks) 5. Able to provide informed consent and comply with study visits and diary.

Exclusion criteria

Exclusion criteria: 1. Alarm features (unexplained weight loss, GI bleeding, persistent fever) requiring further workup. 2. Known organic gastrointestinal disease (IBD, celiac disease, colon cancer). 3. Major psychiatric illness or substance abuse interfering with participation. 4. Pregnant or breastfeeding women. 5. Adults aged below 18 years of age and above 65 years of age. 6. Concurrent participation in another interventional trial. 7. Patients with any co-morbidity.

Design outcomes

Primary

MeasureTime frame
At the end of study, we expect positive response of homoeopathic medicine Gambogia upon IBS.Timepoint: 12 weeks to 16 weeks

Secondary

MeasureTime frame
The study will encourage patients to take homoeopathic medicine for gastrointestinal problems.Timepoint: 12 weeks to 16 weeks

Countries

India

Contacts

Public ContactDr Amit

RBTS Govt Homoeopathic Medical College and Hospital

amitrisdth@gmail.com7765802619

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026